Literature DB >> 11535943

Positive family history of allergy in children with hypersensitivity to cow's milk.

D Korol1, M Kaczmarski.   

Abstract

BACKGROUND: Allergy belongs to the most frequent chronic diseases in developed countries. Its manifestation and development are determined by genetic predisposition as well as specific and non-specific environmental factors. The aim of this paper was to evaluate the type and incidence of allergic/atopic diseases among family members (1st and 2nd degree of kinship) of children with the diagnosis of hypersensitivity to cow's milk.
MATERIAL AND METHODS: Positive family history of atopic and allergic diseases among the closest relatives was analysed in a group of 180 children with the diagnosis of hypersensitivity to cow's milk.
RESULTS: Allergoses were found in 163 (91.1%) families, affecting 55.5%, 36% and 50% mothers, fathers and siblings of the patients, respectively. The disease of the same type as in children was present in 37.2% siblings and in 11.7% parents. Forty-five per cent of patients were from high-risk families, where 2, 3 or 4 relatives were affected by the disease (in 37.8%, 6.7% and 0.56% cases, respectively).
CONCLUSIONS: Clinical manifestation of allergoses differed between various generations of the same family. The systems most often affected by the allergic process were skin, gastrointestinal tract and respiratory system.

Entities:  

Mesh:

Year:  2001        PMID: 11535943

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  2 in total

Review 1.  Useful biomarkers for assessing the adverse health effects of PCBs in allergic children: pediatric molecular epidemiology.

Authors:  Mayumi Tsuji
Journal:  Environ Health Prev Med       Date:  2014-10-26       Impact factor: 3.674

2.  Health-related quality of life in food hypersensitive schoolchildren and their families: parents' perceptions.

Authors:  Birgitta Marklund; Staffan Ahlstedt; Gun Nordström
Journal:  Health Qual Life Outcomes       Date:  2006-08-10       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.